Global Drug and Gene Delivery Systems Market Report By Route of Administration (Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical), By Vector, Viral, Non-viral), By Method (In Situ, Ex Vivo) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11214683
April 2021
Report Formats:
Global Drug and Gene Delivery Systems Market Overview
The key driver impacting the drug and gene delivery systems market is the growing demand for advanced drugs due to the increasing incidence of chronic diseases such as cancer, diabetes, cardiovascular disease, etc. For instance, The National Center for Biotechnology Information (NCBI) report presents that almost one in three adults suffers from multiple chronic conditions (MCCs). The WHO report shows that chronic disease accounts for 60% of the worldwide disease burden in 2020. Globally cancer is responsible for the second most leading cause of death, and it accounted for 9.6 million deaths in 2018. Similarly, diabetes is also one of the most prevalent diseases globally. As per the International Diabetic Federation (IDF), In 2019, over 463 million adults (20-79 years) were living with diabetes, and it is likely to reach 700 million by 2045.  drug and gene delivery systems techniques are widely used to research and develop medicines, vaccines, antibiotics, and therapeutics used for treating such diseases. The escalating incidence of diseases such as diabetes and cancer has created a need for extensive research and enhancing drug discovery operations and research in the fields of biopharmaceuticals and biotechnology. Moreover, the growth in R&D investments with high demand for self-administration and home health care devices contributes to the drug and gene delivery systems market growth in the coming years.
According to Value Market Research, the global drug and gene delivery systems market size was valued at around USD 5000 million in 2020 and is estimated to grow at a CAGR of about 7.5% during the forecast period 2021 to 2027.

The several advancements made in drug and gene delivery systems are estimated to augment drug and gene delivery systems needs in the forecast period. For example, technological advances such as Prodrug formulation particle engineering & particulate systems, nanoparticle technology, liposomes & hydrogels, and three-dimensional printing (3DP) to attain the sustained and controlled release of drugs. However, the high cost involved in the treatment may hamper the market in the long run. Also, the rise in drug recalls negatively impacts the market. The current industry trends, such as the rising investment by the market players to develop innovative drug delivery systems and high focus on R&D of gene delivery systems, are expected to offer new market opportunities for the key players.

The drug and gene delivery systems market is vast, with many local and global players. The drug and gene delivery systems market is extensive, with many international and regional players. The key market leaders follow several strategies to improve their market statuses, such as extending product portfolio, amalgamation, contracts, acquisitions, product upgrades to enlarge their market share across the globe. For instance, in February 2018, Becton, Dickinson, and Company had launched PAXgene. It is a circulating cell-free DNA blood collection tube for the application of pre-natal cancer testing. The important players studied in the report are Novartis AG, Amgen Inc., Oxford BioMedica plc, SIBIONO, Becton, Dickinson, and Company.

Global Drug and Gene Delivery Systems Market Share

In this research report, the drug and gene delivery systems market is segmented by route of administration, vectors, methods, and region.

Analysis by Route of Administration
By route of administration, the report is categorized into oral, inhalation, transdermal, injectable, ocular, nasal, and topical. The oral segment dominates the route of the administration segment with over 25% share in 2020. It is due to the high potency and safety of biotechnology agents that are attracting biopharmaceutical companies to invest mainly in the research and development of these drugs. Moreover, pharmaceutical companies are focusing on reducing the amount of API per dose and increase the bioavailability at the site of action, thus contribute to the oral route of administration of drugs segment growth in the forecast period.

Analysis by Vector:
By vector, the report is categorized into viral and non-viral. Viral dominates the vector segment with over 90% share in 2020. It is because viral vectors allow complex procedures involved in various transfection procedures such as magnetofection, gene gun, hydrodynamic, and ultrasound at the high success rate of the gene transfer than its counterpart techniques. Moreover, more than 60% of the ongoing clinical trials on gene therapies are based on the viral vectors for transfection contributes to the increased demand for viral vectors segment in the forecast period.

Analysis by Method:
By the method, the report is categorized into in situ and ex vivo. In situ dominate the method segment with over 55% share in 2020. It is because most of the recently approved drugs act by in situ methods. Moreover, high focus on the in situ methods owing to their ease of performance contributes to the increased market demand in the forecast period.

Analysis by Region:
In the regional outlook of the global drug and gene delivery systems market, the North America region dominates globally with a 30% market share in the forecast period. It is due to the rising prevalence of chronic diseases in the area, technological advancement, and the domicile presence of significant players in the region. Moreover, the existence of well-established nanotechnology, biotechnology, and pharmaceutical industry, with massive awareness concerning advanced technologies for the treatment of chronic and genetic disease among the population of the U.S. and Canada, contribute to market growth across North America.
 
Market Segmentation covered in the Report:
By Route of Administration
  • Oral
  • Inhalation
  • Transdermal
  • Injectable
  • Ocular
  • Nasal
  • Topical
By Vector
  • Viral
  • Non-viral
By Method
  • In Situ
  • Ex Vivo
By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
METHODOLOGY

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.  

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . DRUG AND GENE DELIVERY SYSTEMS  – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Route of Administration
           3.7.2 By Vector
           3.7.3 By Method
           3.7.4 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL DRUG AND GENE DELIVERY SYSTEMS  MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
       6.1 Overview by Route of Administration
       6.2 Historical and Forecast Data
       6.3 Analysis by Route of Administration
       6.4 Oral Market by Regions
       6.5 Inhalation Market by Regions
       6.6 Transdermal Market by Regions
       6.7 Injectable Market by Regions
       6.8 Ocular Market by Regions
       6.9 Nasal Market by Regions
       6.10. Topical Market by Regions
 
7 . GLOBAL DRUG AND GENE DELIVERY SYSTEMS  MARKET ANALYSIS BY VECTOR
       7.1 Overview by Vector
       7.2 Historical and Forecast Data
       7.3 Analysis by Vector
       7.4 Viral Market by Regions
       7.5 Non-viral Market by Regions
 
8 . GLOBAL DRUG AND GENE DELIVERY SYSTEMS  MARKET ANALYSIS BY METHOD
       8.1 Overview by Method
       8.2 Historical and Forecast Data
       8.3 Analysis by Method
       8.4 In Situ Market by Regions
       8.5 Ex Vivo Market by Regions
 
9 . GLOBAL DRUG AND GENE DELIVERY SYSTEMS  MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview, Historic and Forecast Data
           9.3.2. North America By Segment
           9.3.3. North America By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview, Historic and Forecast Data
           9.4.2. Europe by Segment
           9.4.3. Europe by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview, Historic and Forecast Data
           9.5.2. Asia Pacific by Segment
           9.5.3. Asia Pacific by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview, Historic and Forecast Data
           9.6.2. Latin America by Segment
           9.6.3. Latin America by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview, Historic and Forecast Data
           9.7.2. Middle East & Africa by Segment
           9.7.3. Middle East & Africa by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa
 
10 . COMPETITIVE LANDSCAPE OF THE DRUG AND GENE DELIVERY SYSTEMS  COMPANIES
       10.1. Drug And Gene Delivery Systems  Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF DRUG AND GENE DELIVERY SYSTEMS  INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Novartis AG
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Amgen Inc.
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Oxford BioMedica plc
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. SIBIONO
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Becton
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Dickinson
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Route of Administration (USD MN)
  •  Oral Market by Geography (USD MN)
  •  Inhalation Market by Geography (USD MN)
  •  Transdermal Market by Geography (USD MN)
  •  Injectable Market by Geography (USD MN)
  •  Ocular Market by Geography (USD MN)
  •  Nasal Market by Geography (USD MN)
  •  Topical Market by Geography (USD MN)
  •  Analysis Market by Vector (USD MN)
  •  Viral Market by Geography (USD MN)
  •  Non-viral Market by Geography (USD MN)
  •  Analysis by Method (USD MN)
  •  In Situ Market by Geography (USD MN)
  •  Ex Vivo Market by Geography (USD MN)
  •  Global Drug And Gene Delivery Systems  Market by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
 
 LIST OF FIGURES
 
  •  Research Scope of Drug And Gene Delivery Systems  Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Drug And Gene Delivery Systems  Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Route of Administration
  •  Market Attractiveness Analysis by Vector
  •  Market Attractiveness Analysis by Method
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Route of Administration (USD MN)
  •  Oral Market by Geography (USD MN)
  •  Inhalation Market by Geography (USD MN)
  •  Transdermal Market by Geography (USD MN)
  •  Injectable Market by Geography (USD MN)
  •  Ocular Market by Geography (USD MN)
  •  Nasal Market by Geography (USD MN)
  •  Topical Market by Geography (USD MN)
  •  Global Market Analysis by Vector (USD MN)
  •  Viral Market by Geography (USD MN)
  •  Non-viral Market by Geography (USD MN)
  •  Global Market Analysis by Method (USD MN)
  •  In Situ Market by Geography (USD MN)
  •  Ex Vivo Market by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Company Market Share Analysis, 2020
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials